 CAMBRIDGE, Mass.--BUSINESS WIRE--Sage Therapeutics, Inc. Nasdaq: SAGE, a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will give a presentation at the 2022 Stifel CNS Days on Tuesday, March 29, 2022 at 4:00pm ET. A live webcast of the presentation can be accessed on the Investor page of Sages website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the e 